Lyell Immunopharma, Inc.

Q4 2021 13F Holders

Symbol: LYEL
CUSIP: 55083R104
Type: Equity
Class: COM
Num filings: 80
Total reported value, excl. options: $662 M

Compare 2021 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type